Debajit K Biswas

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. doi request reprint NF-κB Activation-Induced Anti-apoptosis Renders HER2-Positive Cells Drug Resistant and Accelerates Tumor Growth
    Shannon T Bailey
    Department of Cancer Biology, Dana Farber Cancer Institute, 450 Brookline Avenue, Smith 958, Boston, MA 02215
    Mol Cancer Res 12:408-20. 2014
  2. ncbi request reprint Apoptosis caused by chemotherapeutic inhibition of nuclear factor-kappaB activation
    Debajit K Biswas
    Dana Farber Cancer Institute, Department of Cancer Biology, Boston, Massachusetts 02115, USA
    Cancer Res 63:290-5. 2003
  3. pmc NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis
    Debajit K Biswas
    Department of Cancer Biology, Dana Farber Cancer Institute, Boston, MA 02115, USA
    Proc Natl Acad Sci U S A 101:10137-42. 2004
  4. ncbi request reprint Crossroads of estrogen receptor and NF-kappaB signaling
    Debajit K Biswas
    Department of Cancer Biology, Dana Farber Cancer Institute, Brigham and Women s Hospital, Boston, MA 02115, USA
    Sci STKE 2005:pe27. 2005
  5. ncbi request reprint Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer
    Debajit K Biswas
    Department of Cancer Biology, Dana Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA
    J Cell Physiol 209:645-52. 2006
  6. ncbi request reprint Nuclear factor-kappaB activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer
    Sindhu Singh
    Department of Cancer Biology, Dana Farber Cancer Institute, Smith Room 1058, 44 Binney Street, Boston, MA 02115, USA
    Mol Cancer Ther 6:1973-82. 2007

Collaborators

Detail Information

Publications6

  1. doi request reprint NF-κB Activation-Induced Anti-apoptosis Renders HER2-Positive Cells Drug Resistant and Accelerates Tumor Growth
    Shannon T Bailey
    Department of Cancer Biology, Dana Farber Cancer Institute, 450 Brookline Avenue, Smith 958, Boston, MA 02215
    Mol Cancer Res 12:408-20. 2014
    ..Implications: The combination of an inhibitor of IκB kinase (IKK) inhibitor and anti-HER2 drugs may be a novel treatment strategy for drug-resistant human breast cancers. Mol Cancer Res; 12(3); 408-20. ©2013 AACR. ..
  2. ncbi request reprint Apoptosis caused by chemotherapeutic inhibition of nuclear factor-kappaB activation
    Debajit K Biswas
    Dana Farber Cancer Institute, Department of Cancer Biology, Boston, Massachusetts 02115, USA
    Cancer Res 63:290-5. 2003
    ..These results and our previous studies suggest the practicality of a target-directed chemotherapy for EGF-responsive breast cancers, by blocking NF-kappaB activation and thereby reinstating apoptosis...
  3. pmc NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis
    Debajit K Biswas
    Department of Cancer Biology, Dana Farber Cancer Institute, Boston, MA 02115, USA
    Proc Natl Acad Sci U S A 101:10137-42. 2004
    ....
  4. ncbi request reprint Crossroads of estrogen receptor and NF-kappaB signaling
    Debajit K Biswas
    Department of Cancer Biology, Dana Farber Cancer Institute, Brigham and Women s Hospital, Boston, MA 02115, USA
    Sci STKE 2005:pe27. 2005
    ..Thus, ER ligands that selectively block NF-kappaB activation could provide specific potential therapy for hormone-resistant ER-positive breast cancers...
  5. ncbi request reprint Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer
    Debajit K Biswas
    Department of Cancer Biology, Dana Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA
    J Cell Physiol 209:645-52. 2006
    ..The combined influence of EGFR family receptors and NF-kappaB signaling on the transformation of ER-negative human mammary epithelial cell is illustrated...
  6. ncbi request reprint Nuclear factor-kappaB activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer
    Sindhu Singh
    Department of Cancer Biology, Dana Farber Cancer Institute, Smith Room 1058, 44 Binney Street, Boston, MA 02115, USA
    Mol Cancer Ther 6:1973-82. 2007
    ..It is postulated that this transcription factor and its activation cascade offer therapeutic targets for erbB2-positive and ER-negative breast cancer...